News, insights and blogs
Sign up to our monthly newsletter to receive our news and insights directly.
All
- All
- Blogs
- Insights
- News
SETsquared Partnership universities and QantX announce new £300m investment vehicle to drive innovation and growth in the South and West
The SETsquared Partnership universities and leading regional investment firm QantX have announced plans for a new £300m spin-out focused investment vehicle to catalyse the creation and growth of science and...
Advanced materials noise management startup wins Tech-Xpo award
A startup that engineers advanced materials for sound and noise management won Best Elevator Pitch at our Tech-Xpo 2024 Showcase. Gianluca Memoli, CEO of Metasonixx, delivered part of his winning...
Kimberley Brook: Farewell – reflections from my time at SETsquared Bristol
After a wonderful few years working with SETsquared Bristol, my time at the tech incubator has come to an end as I move on to a new role as Head...
Healthtech spotlight: SoleSense
A year on from SoleSense’s Best Elevator Pitch award at our flagship Tech-Xpo showcase, we had a chat with Founder and CEO, Caz Icke, to hear her story. SoleSense at...
Tech-Xpo celebrates 20 years shining a light on trailblazing tech
We’re thrilled to be celebrating 20 years of Tech-Xpo, our flagship pitch, demo and connect showcase, this autumn. Sixteen startups will promote their innovative technologies to an audience of over 150 business leaders and...
DRIFT Energy plans first green hydrogen-producing vessel build following seed investment
DRIFT Energy has announced the close of its seed funding round led by Octopus Ventures, and with support from Blue Action Accelerator, the company has secured a total of £4.65...
FluoretiQ patent granted to enable fast and accurate antibiotic testing
Bristol-based biotech company, FluoretiQ, who is developing fast and accurate point-of-care testing for Urinary Tract Infections (UTIs) and Sexually Transmitted Diseases (STDs), has taken a significant step forward after having...
GenomeKey awarded $11.4M to transform sepsis diagnosis and treatment
GenomeKey has been awarded a major grant from Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to build a functioning, automated prototype of their desktop diagnostic device. The Bristol-based company joined our...
Your success is our success
We’ve helped over 450 companies, in 20+ sectors, raise over £742 million in investment.